A reversed sulfonamide series of selective RORc inverse agonists
- 1 December 2014
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 24 (24) , 5769-5776
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Institute of General Medical Sciences
- Howard Hughes Medical Institute
- Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy (DE-AC02-05CH11231)
This publication has 33 references indexed in Scilit:
- Inhibiting RORγt/Th17 axis for autoimmune disordersDrug Discovery Today, 2014
- Action of RORs and their ligands in (patho)physiologyTrends in Endocrinology & Metabolism, 2012
- Structural Basis for Hydroxycholesterols as Natural Ligands of Orphan Nuclear Receptor RORγMolecular Endocrinology, 2010
- Modulation of Retinoic Acid Receptor-related Orphan Receptor α and γ Activity by 7-Oxygenated Sterol LigandsJournal of Biological Chemistry, 2010
- The Biological Functions of T Helper 17 Cell Effector Cytokines in InflammationImmunity, 2008
- Orphan nuclear receptors in drug discoveryDrug Discovery Today, 2007
- The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper CellsCell, 2006
- Retinoid‐related orphan receptors (RORs): Roles in cellular differentiation and development2006
- Orphan nuclear receptors adopted by crystallographyCurrent Opinion in Structural Biology, 2005
- A canonical structure for the ligand-binding domain of nuclear receptorsNature Structural & Molecular Biology, 1996